Published in Anticancer Res on November 28, 2001
Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol (2012) 0.94
Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans. J Exp Clin Cancer Res (2009) 0.81
Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy. J Cell Mol Med (2015) 0.80
Electrochemotherapy in treatment of tumours. Eur J Surg Oncol (2007) 2.51
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res (1995) 1.85
Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Res (2001) 1.75
The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J (1998) 1.61
Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol (2012) 1.55
Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer (2008) 1.53
Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat (2011) 1.50
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des (2006) 1.31
Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res (2000) 1.19
Tumour blood flow changes induced by application of electric pulses. Eur J Cancer (1999) 1.17
Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res (2000) 1.11
Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer (1998) 1.10
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer (1999) 1.05
Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer (2001) 1.03
Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br J Cancer (2002) 1.01
Electrochemotherapy in veterinary oncology. J Vet Intern Med (2008) 0.99
Limitations of the reporter green fluorescent protein under simulated tumor conditions. Cancer Res (2001) 0.99
Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: case report and literature review. Tumori (2000) 0.98
Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. Cancer Lett (1997) 0.95
Control by pulse parameters of DNA electrotransfer into solid tumors in mice. Gene Ther (2009) 0.94
Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res (2000) 0.93
Muscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Ther (2011) 0.91
Reduced tumor oxygenation by treatment with vinblastine. Cancer Res (2001) 0.90
Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res (1998) 0.89
Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs (1998) 0.88
Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors. Int J Radiat Oncol Biol Phys (2000) 0.88
Improved photo-CIDNP methods for studying protein structure and folding. J Biomol NMR (2000) 0.87
In vivo evolution of tumour cells after the generation of double-strand DNA breaks. Br J Cancer (2003) 0.87
Electrochemotherapy of mouse sarcoma tumors using electric pulse trains with repetition frequencies of 1 Hz and 5 kHz. J Membr Biol (2010) 0.86
Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice--natural resistance and immune responsiveness. Anticancer Drugs (1996) 0.85
Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin. Anticancer Res (1999) 0.84
The effect of the histological properties of tumors on transfection efficiency of electrically assisted gene delivery to solid tumors in mice. Gene Ther (2007) 0.84
Efficient electrotransfection into canine muscle. Technol Cancer Res Treat (2008) 0.84
MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo. Cancer Gene Ther (2010) 0.84
Modification of TNF-alpha pharmacokinetics in SA-1 tumor-bearing mice. Int J Cancer (1993) 0.84
Determination of platinum in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry. J Pharm Biomed Anal (1997) 0.83
Electrochemotherapy of tumours. Curr Oncol (2009) 0.82
Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. Eur J Cancer (2001) 0.81
Electric treatment of human melanoma skin lesions with low level direct electric current: an assessment of clinical experience following a preliminary study in five patients. Eur J Surg Suppl (1994) 0.81
Gene electrotransfer of siRNAs against CD146 inhibits migration and invasion of human malignant melanoma cells SK-MEL28. Cancer Gene Ther (2013) 0.81
Effect of hydralazine on interstitial fluid pressure in experimental tumours and in normal tissue. In Vivo (2001) 0.80
Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH. Br J Radiol (2000) 0.79
Blood perfusion of subcutaneous tumours in mice following the application of low-level direct electric current. Adv Exp Med Biol (1999) 0.78
Modified cell proliferation due to electrical currents. Med Biol Eng Comput (1992) 0.77
The influence of TNF on the membrane fluidity of tumor cells. Cancer Lett (1992) 0.77
Electrochemotherapy of solid tumors--preclinical and clinical experience. Conf Proc IEEE Eng Med Biol Soc (2011) 0.76
Inoperable oropharyngeal carcinoma treated with concomitant irradiation, mitomycin C and bleomycin - long term results. Neoplasma (2005) 0.76
EPR oximetry: reduction of cell respiration by vinblastine. Pflugers Arch (1996) 0.75
Searching for new TNF-alpha analogs having potential application in cancer therapy. Pflugers Arch (1996) 0.75
New TNF-alpha analogues: a powerful but less toxic biological tool against tumours. Cytokine (1997) 0.75
In vitro monocyte maturation in patients with malignant melanoma and colorectal cancer--clinical significance. Neoplasma (1986) 0.75
Adoptive immunotherapy as an adjunctive treatment to thoracic irradiation for pulmonary tumor deposits in mice. Cancer Res (1989) 0.75
Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice. Anticancer Res (2001) 0.75
Use of nitric acid in sample pretreatment for determination of trace elements in various biological samples by ETAAS. J Pharm Biomed Anal (2000) 0.75
Interactions of interferon and vinblastine on experimental tumor model melanoma B-16 in vitro. Anticancer Drugs (1994) 0.75
Effects of vinblastine on cell membrane fluidity and the growth of SA-1 tumor in mice. Cancer Lett (1994) 0.75
Effect of vinblastine on cell membrane fluidity in vinblastine-sensitive and -resistant HeLa cells. Cancer Lett (1998) 0.75
Antitumor effectiveness of bolus versus split dose vinblastine treatment in EAT tumors in mice. Anticancer Res (1998) 0.75